{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:34:08Z","timestamp":1767713648761,"version":"3.41.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Recognition of the pattern of FDG uptake in hypermetabolic axillary lymph nodes (HALs) and association with recent messenger RNA (mRNA) vaccination are important to prevent patient anxiety and further needless examinations or costly biopsies in cancer patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods<\/jats:title>\n            <jats:p>This study was a retrospective cohort study in a single tertiary care institution. We investigate the occurrence and pattern of HAL on FDG PET\/CT scans from 650 consecutive cancer patients with recent BNT162b2 mRNA COVID-19 vaccination.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Between December 20, 2020, and February 8, 2021, 650 patients (351 female patients [54%]; mean age, 68.9 years) had recent mRNA COVID-19 vaccination and an FDG PET\/CT scan. HALs were found in 57 (14.5%) of 394 patients (95% confidence interval [CI], 10.9%\u201318.7%) 12.3 \u00b1 5.9 (1\u201322) days after dose 1 and in 111 (43.3%) of 256 patients (95% CI, 35.3%\u201352.2%; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001) after 7.5 \u00b1 5.4 (1\u201322) days after dose 2. There was no difference between dose 1 and dose 2 concerning SUV<jats:sub>max<\/jats:sub> (3.7 \u00b1 1.8 [1.3\u201311.3] and 4.5 \u00b1 3.9 [1.4\u201326.3], <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.13, respectively), SUV<jats:sub>mean<\/jats:sub> (2.1 \u00b1 1.0 [0.7\u20136.5] and 2.7 \u00b1 2.4 [0.8\u201317], <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.08, respectively), and reactogenicity volume (2.7 \u00b1 2.3 [0.2\u201311.6] cm<jats:sup>3<\/jats:sup> and 2.7 \u00b1 2.4 [0.2\u201315.5] cm<jats:sup>3<\/jats:sup>, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.98, respectively). There was no difference in number and in size of positive lymph nodes between dose 1 and dose 2: 3.2 \u00b1 2.2 (1\u201310) and 3.7 \u00b1 2.4 (1\u201312) (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.18), and 1.4 \u00b1 0.4 cm (0.7\u20132.5 cm) and 1.5 \u00b1 0.4 cm (0.6\u20133.2 cm) (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.75), respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>A cluster pattern of hypermetabolic ipsilateral small axillary lymph nodes is common after mRNA COVID-19 vaccination, mainly after the second injection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000003648","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T04:03:28Z","timestamp":1617077008000},"page":"396-401","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":40,"title":["Axillary Lymph Nodes Hypermetabolism After BNT162b2 mRNA COVID-19 Vaccination in Cancer Patients Undergoing 18F-FDG PET\/CT"],"prefix":"10.1097","volume":"46","author":[{"given":"Hanna","family":"Bernstine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Priss","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Rabin Medical Center, Petah Tikva"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer","family":"Anati","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Rabin Medical Center, Petah Tikva"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Turko","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Rabin Medical Center, Petah Tikva"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Gorenberg","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Bnai Zion Medical Center and Faculty of Medicine, The Technion\u2013Israel Institute of Technology, Haifa, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam Peter","family":"Steinmetz","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Rabin Medical Center, Petah Tikva"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Groshar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,30]]},"reference":[{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s00259-011-1729-9","article-title":"Duration of (18)F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccination","volume":"38","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/RLU.0b013e3182177322","article-title":"Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine","volume":"36","year":"2011","journal-title":"Clin Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12149-011-0568-x","article-title":"Axillary lymph node accumulation on FDG-PET\/CT after influenza vaccination","volume":"26","year":"2012","journal-title":"Ann Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00330-010-1719-5","article-title":"FDG uptake in axillary lymph nodes after vaccination against pandemic (H1N1)","volume":"20","year":"2010","journal-title":"Eur Radiol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clinimag.2021.01.016","article-title":"Unilateral axillary adenopathy in the setting of COVID-19 vaccine","volume":"75","year":"2021","journal-title":"Clin Imaging"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"e210008","DOI":"10.1148\/ryct.2021210008","article-title":"Axillary lymphadenopathy after mRNA COVID-19 vaccination","volume":"3","year":"2021","journal-title":"Radiol Cardiothorac Imaging"},{"key":"bib11-20250621","first-page":"210030","article-title":"Imaging of COVID-19 vaccination at FDG PET\/CT","year":"2021","journal-title":"Radiology"},{"journal-title":"Clin Nucl Med","article-title":"COVID-19 mRNA vaccination-induced lymphadenopathy mimics lymphoma progression on FDG PET\/CT","year":"2021","key":"bib12-20250621"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/clinids\/7.5.613","article-title":"Effect of cancer chemotherapy on the immune response to influenza virus vaccine: review of published studies","volume":"7","year":"1985","journal-title":"Rev Infect Dis"},{"key":"bib14-20250621","first-page":"CD006484","article-title":"Influenza vaccination in children being treated with chemotherapy for cancer","volume":"15","year":"2009","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:03:47Z","timestamp":1750539827000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003648"}},"subtitle":["A Cohort Study"],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003648","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2021,3,30]]}}}